Depression Reappraisal and Treatment Effect: Will Response Shift Help Improve the Estimation of Treatment Efficacy in Trials for Mood Disorders?

Front Psychiatry. 2019 Jun 27:10:420. doi: 10.3389/fpsyt.2019.00420. eCollection 2019.

Samuel Bulteau^{1

2}, Anne Sauvaget^{2

3}, Antoine Vanier¹, Jean-Marie Vanelle², Emmanuel Poulet^{4

5}, Jérome Brunelin⁴, Véronique Sebille^{1

6}

¹ INSERM-U1246 SPHERE University of Nantes and University of Tours, Nantes, France.
² CHU Nantes, Department of Addictology and Psychiatry, Nantes, France.
³ Laboratory "Movement, Interactions, Performance" (E.A. 4334), Faculty of Sport Sciences, University of Nantes, Nantes, France.
⁴ INSERM-U1028, CNRS-UMR5292, Lyon Neuroscience Research Center, ΨR2 Team, University of Lyon, CH Le Vinatier, Lyon, France.
⁵ Department of Emergency Psychiatry, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France.
⁶ CHU Nantes, Department of Methodology and Biostatistics, Nantes, France.

No abstract available

Keywords: depression; efficacy; patient-reported outcomes; reappraisal; response shift.